Mitogen-Activated Protein Kinase Proteins Regulate LPS-Stimulated Release of Pro-inflammatory Cytokines and Prostaglandins from Human Gestational Tissues

Placenta

Volumn 28, Issue 8-9, 2007, Pages 936-945

  Lappas, M ^a   Permezel, M ^a   Rice, G E ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Cytokines; ERK 1 2; Fetal membranes; JNK; p38 MAPK; Placenta; Prostaglandins

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROSTAGLANDIN; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FETUS MEMBRANE; HUMAN; HUMAN TISSUE; INCUBATION TIME; INFLAMMATION; LABOR; PLACENTA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; TISSUE CULTURE; WESTERN BLOTTING; METABOLISM;

CYTOKINES; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROSTAGLANDINS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34447525671     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2007.02.009     Document Type: Article

References (39)

1. Gibb W. The role of prostaglandins in human parturition. Ann Med 30 (1998) 235-241
2. Rice G.E. Cytokines and the initiation of parturition. Front Horm Res 27 (2001) 113-146
3. 2 isozymes in pregnancy and parturition. Prostaglandins Leukot Essent Fatty Acids 70 (2004) 87-100
4. Menon R., and Fortunato S.J. The role of matrix degrading enzymes and apoptosis in rupture of membranes. J Soc Gynecol Investig 11 (2004) 427-437
5. Lappas M., and Rice G.E. The role and regulation of the Nuclear Factor Kappa B signalling pathway in human labour. Placenta 28 (2007) 543-556
6. Dong C., Davis R.J., and Flavell R.A. MAP kinases in the immune response. Annu Rev Immunol 20 (2002) 55-72
7. Kumar S., Boehm J., and Lee J.C. p38 map kinases: key signalling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2 (2003) 717-726
8. Manning A.M., and Davis R.J. Targeting JNK for therapeutic benefit: from JuNK to gold?. Nat Rev Drug Discov 2 (2003) 554-565
9. Boldt S., and Kolch W. Targeting MAPK signalling: prometheus' fire or pandora's box?. Curr Pharm Des 10 (2004) 1885-1905
10. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68 (2004) 320-344
11. English J.M., and Cobb M.H. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 23 (2002) 40-45
12. Turner M.A., Shaikh S.A., and Greenwood S.L. Secretion of interleukin-1β and interleukin-6 by fragments of term human placental villi: signalling pathways and effects of tumour necrosis factor α and mode of delivery. Placenta 23 (2002) 467-474
13. Yoshino O., Osuga Y., Hirota Y., Koga K., Hirata T., Yano T., et al. Endometrial stromal cells undergoing decidualization down-regulate their properties to produce proinflammatory cytokines in response to interleukin-1β via reduced p38 mitogen-activated protein kinase phosphorylation. J Clin Endocrinol Metab 88 (2003) 2236-2241
14. Sooranna S.R., Engineer N., Loudon J.A.Z., Terzidou V., Bennett P.R., and Johnson M.R. The MAPK dependent expression of prostaglandin H synthase-2 and interleukin-8 mRNA by myometrial cells: the differential effect of stretch and interleukin-1β. J Clin Endocrinol Metab 90 (2005) 3517-3527
15. 12,14-PGJ2 and troglitazone. J Clin Endocrinol Metab 87 (2002) 4667-4672
16. Lappas M., Permezel M., and Rice G.E. N-Acetyl-cysteine inhibits phospholipid metabolism, pro-inflammatory cytokine release, protease activity, and nuclear factor-κB deoxyribonucleic acid-binding activity in human fetal membranes in vitro. J Clin Endocrinol Metab 88 (2003) 1723-1729
17. Yazlovitskaya E.M., Pelling J.C., and Persons D.L. Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor α-resistant ovarian carcinoma cell line UCI 101. Mol Carcinog 25 (1999) 14-20
18. Venkatakrishnan G., Salgia R., and Groopman J.E. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275 (2000) 6868-6875
19. Bartlett S.R., Sawdy R., and Mann G.E. Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1 beta: involvement of p38 mitogen-activated protein kinase. J Physiol 520 (1999) 399-406
20. Jung H., Yoon B., Jun J., Kim M., Kim Y., and Kim C. Differential activation of mitogen activated protein kinases and nuclear factor-κB in lipopolysaccharide-treated term and preterm amnion cells. Virchows Arch 447 (2005) 45-52
21. Adams J.L., Badger A.M., Kumar S., and Lee J.C. p38 MAP kinase: molecular target for the inhibition of pro-inflammatory cytokines. Prog Med Chem 38 (2001) 1-60
22. Yamauchi N., Harada T., Taniguchi F., Yoshida S., Iwabe T., and Terakawa N. TNF-α induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-κB and mitogen-activated protein kinase pathways. Fertil Steril 82 (2004) 1023-1028
23. Swantek J.L., Cobb M.H., and Geppert T.D. Jun N-terminal kinase stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor α (TNF-α) translation: glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK. Mol Cell Biol 17 (1997) 6274-6282
24. Ishizuka T., Terada N., Gerwins P., Hamelmann E., Oshiba A., Fanger G.R., et al. Mast cell tumor necrosis factor α production is regulated by MEK kinases. Proc Natl Acad Sci U S A 94 (1997) 6358-6363
25. Rockwell P., Martinez J., Papa L., and Gomes E. Redox regulates COX-2 upregulation and cell death in the neuronal response to cadmium. Cell Signal 16 (2004) 343-353
26. Chien P.S., Mak O.T., and Huang H.J. Induction of COX-2 protein expression by vanadate in A549 human lung carcinoma cell line through EGF receptor and p38 MAPK-mediated pathway. Biochem Biophys Res Commun 339 (2006) 562-568
27. Thomas B., Thirion S., Humbert L., Tan L., Goldring M.B., Bereziat G., et al. Differentiation regulates interleukin-1β-induced cyclo-oxygenase-2 in human articular chondrocytes: role of p38 mitogen-activated protein kinase. Biochem J 362 (2002) 367-373
28. Waetzig V., Czeloth K., Hidding U., Mielke K., Kanzow M., Brecht S., et al. c-Jun N-terminal kinases (JNKs) mediate pro-inflammatory actions of microglia. Glia 50 (2005) 235-246
29. 2 and cyclooxygenase-2 in astrocytes: synergy with interleukin-1β, tumor necrosis factor-α, and bacterial lipopolysaccharide. Glia 42 (2003) 433-446
30. 2 in primary human bronchial epithelial cells. Cytokine 25 (2004) 11-20
31. 2 production in human myometrial cells: role of a pertussis toxin-sensitive component. Am J Reprod Immunol 45 (2001) 142-147
32. 2α in intact fetal membranes. Placenta 19 (1998) 625-630
33. Giroux S., Tremblay M., Bernard D., Cadrin-Girard J.F., Aubry S., Larouche L., et al. Embryonic death of Mek1-deficient mice reveals a role for this kinase in angiogenesis in the labyrinthine region of the placenta. Curr Biol 9 (1999) 369-372
34. Hatano N., Mori Y., Oh-Hora M., Kosugi A., Fujikawa T., Nakai N., et al. Essential role for ERK2 mitogen-activated protein kinase in placental development. Genes Cells 8 (2003) 847-856
35. Kuida K., and Boucher D.M. Functions of MAP kinases: insights from gene-targeting studies. J Biochem 135 (2004) 653-656
36. Brar A.K., Richards R.G., Cheng Y.H., Richardson B., Kanda Y., and Handwerger S. Mitogen-activated protein kinase activates human placental lactogen-B enhancer by an NF-IL6-dependent pathway. Endocrine 12 (2000) 47-52
37. Cheng Y.H., and Handwerger S. Mitogen-activated protein kinase activation induces corticotrophin-releasing hormone gene expression in human placenta. Life Sci 77 (2005) 1263-1272
38. Sweeney S.E., and Firestein G.S. Signal transduction in rheumatoid arthritis. Curr Opin Rheumatol 16 (2004) 231-237
39. Duan W., and Wong W.S.F. Targeting mitogen-activated protein kinases for asthma. Curr Drug Ther 7 (2006) 691-698